Journal articles on the topic 'Approval stage'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Approval stage.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Kochan, Iryna. "Ukrainian Terminology: Approval Stage." Terminological Bulletin, no. 5 (2019): 25–32. http://dx.doi.org/10.37919/2221-8807-2019-5-3.
Full textOliveira, Bruna Andrade dos Santos, Lucas de Oliveira Bernardes, Adriano Menis Ferreira, et al. "Impact of Educational Intervention on Cleaning and Disinfection of an Emergency Unit." International Journal of Environmental Research and Public Health 17, no. 9 (2020): 3313. http://dx.doi.org/10.3390/ijerph17093313.
Full textReddy, D. Samba. "An Overview of Novel Drugs and New Chemical Entities in 2013." International Journal of Pharmaceutical Sciences and Nanotechnology 7, no. 3 (2014): 2505–8. http://dx.doi.org/10.37285/ijpsn.2014.7.3.1.
Full text&NA;. "Mitoxantrone nearing approval for late-stage prostate cancer." Inpharma Weekly &NA;, no. 1055 (1996): 22. http://dx.doi.org/10.2165/00128413-199610550-00046.
Full textFrantz, John A. "Two-stage drug approval would reduce the risks." Nature 435, no. 7039 (2005): 143. http://dx.doi.org/10.1038/435143b.
Full textCaggiano, Vincent, and Carol Parise. "Who gets treated at commission on cancer-approved programs and does it make a difference in survival?" Journal of Clinical Oncology 31, no. 26_suppl (2013): 114. http://dx.doi.org/10.1200/jco.2013.31.26_suppl.114.
Full textDawood, S. S., C. Albaracin, A. Gonzalez-Angulo, M. Markman, and B. Hennessy. "Effect of introduction of paclitaxel on survival among women with stage III and IV ovarian cancer." Journal of Clinical Oncology 27, no. 15_suppl (2009): 5536. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5536.
Full textDiMasi, Joseph A., and Henry G. Grabowski. "Economics of New Oncology Drug Development." Journal of Clinical Oncology 25, no. 2 (2007): 209–16. http://dx.doi.org/10.1200/jco.2006.09.0803.
Full text&NA;. "FDA Approval for Zykadia for Late-Stage Lung Cancer." Oncology Times 36, no. 10 (2014): 8. http://dx.doi.org/10.1097/01.cot.0000450371.08810.54.
Full textHarris, Tina. "Gaining approval for clinical research in third stage management." British Journal of Midwifery 6, no. 8 (1998): 532–34. http://dx.doi.org/10.12968/bjom.1998.6.8.532.
Full textSofaer, Neema, and Nir Eyal. "Translational Research Beyond Approval: A Two-Stage Ethics Review." American Journal of Bioethics 10, no. 8 (2010): W1—W3. http://dx.doi.org/10.1080/15265161.2010.500199.
Full textAhmed, Sagheer. "Lessons from the Aducanumab Approval Saga." Molecular Medicine Communications 2, no. 01 (2022): 01. http://dx.doi.org/10.55627/mmc.002.001.0077.
Full textKipli, Kumalasari, Fara Diva Mustapa, Shariffah Zatil Hidayah Syed Jamaluddin, and Favilla Zaini. "KNOWLEDGE MANAGEMENT PROCESS IMPLEMENTATION IN PRIVATE FINANCE INITIATIVE PROJECT IN MALAYSIA." Journal of Information System and Technology Management 6, no. 24 (2021): 109–17. http://dx.doi.org/10.35631/jistm.624011.
Full textMaria, Sylvia Macchione Saes. "Editorial Facing the challenge of the desk review approval." RAUSP Management Journal 53, no. 2 (2018): 139–40. https://doi.org/10.5281/zenodo.2602129.
Full textD., Sarika Prathyusha* Brahmaiah Bonthagarala M.V. Ngabhushanam and D. Nagarjuna Reddy. "MARKETING AUTHORIZATION PROCESS OF NEW DRUG SUBSTANCES IN U.S.A AND EUROPE." Indo American Journal of Pharmaceutical Sciences 04, no. 06 (2017): 1690–98. https://doi.org/10.5281/zenodo.821854.
Full textCoerver, Katherine, Melissa M. Yu, Anelyssa D'Abreu, Marc Wasserman, and Kavita V. Nair. "Practical Considerations in the Administration of Aducanumab for the Neurologist." Neurology: Clinical Practice 12, no. 2 (2021): 169–75. http://dx.doi.org/10.1212/cpj.0000000000001144.
Full text&NA;. "FDA Approval for Cetuximab for Late-Stage Head & Neck Cancer." Oncology Times 33, no. 23 (2011): 24. http://dx.doi.org/10.1097/01.cot.0000410211.22294.ce.
Full textVytovtov, Aleksey, Andrey Kalach, and Pavel Ageev. "FIRE PROTECTION SYSTEMS EXAMINATION AT THE SPECIAL TECHNICAL CONDITIONS APPROVAL STAGE." Problems of risk management in the technosphere 2024, no. 4 (2024): 51–61. https://doi.org/10.61260/1998-8990-2025-2024-4-51-61.
Full textIurash, I. "Peace agreements at certain stages of the civil process." Uzhhorod National University Herald. Series: Law 1, no. 78 (2023): 251–56. http://dx.doi.org/10.24144/2307-3322.2023.78.1.40.
Full textLamba, Nayan, Timothy Smith, and Bryan Iorgulescu. "IMMU-02. THE SURVIVAL OUTCOMES ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS FOR NON-SMALL CELL LUNG CARCINOMA PATIENTS WITH BRAIN METASTASES IN THE UNITED STATES." Neuro-Oncology 22, Supplement_2 (2020): ii104—ii105. http://dx.doi.org/10.1093/neuonc/noaa215.433.
Full textMendenhall, William M., Stephanie Smith, Christopher G. Morris, et al. "Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer." International Journal of Particle Therapy 6, no. 2 (2019): 26–30. http://dx.doi.org/10.14338/ijpt-19-00070.1.
Full textZou, Denise, Eileen Zhang, Sherry Wu, and Virgil Rose. "Use of Single-Arm Trials in FDA Approvals of Treatments in Relapsed or Refractory B-Cell Lymphoma." Blood 142, Supplement 1 (2023): 7250. http://dx.doi.org/10.1182/blood-2023-189855.
Full textWhite, Richard L., Sally Jeanne Trufan, Nicole Lee Gower, Brittany Neelands, and Asim Amin. "Disparities in use of immunotherapy for stage III and IV melanoma patients." Journal of Clinical Oncology 38, no. 15_suppl (2020): e19087-e19087. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e19087.
Full textBekimbetova, G. "ANALYSIS AND EVALUATION OF THE EFFICIENCY OF INVESTMENT PROJECTS IN THE REPUBLIC OF UZBEKISTAN." Slovak international scientific journal, no. 63 (May 10, 2022): 30–34. https://doi.org/10.5281/zenodo.6535033.
Full textKuzmin, Stanislav E. "Mergers and Acquisitions of Joint Stock Companies in Russia and Corporations in the US (legal regulation experience)." Moscow Journal of International Law 96, no. 4 (2014): 163–74. http://dx.doi.org/10.24833/0869-0049-2014-4-163-174.
Full textFedoreshchenko, Nikolay, and Mihail Levitin. "PRELIMINARY ANALYSIS OF THE MODERNIZATION OF METAL-CUTTING MACHINES." Bulletin of the Angarsk State Technical University 1, no. 15 (2022): 78–81. http://dx.doi.org/10.36629/2686-777x-2021-1-15-78-81.
Full textRafi, Achmad, Muharman Lubis, R. Wahjoe Witjaksono, and Nguyen Kieu Trang. "Development Of Means Of Engagement (Moe) Concepts For The Use Of Enterprise Resource Planning (Erp) At The Approval Level." Electronic Integrated Computer Algorithm Journal 1, no. 1 (2023): 32–40. http://dx.doi.org/10.62123/enigma.v1i1.4.
Full textCurtin, Nicola J. "The Development of Rucaparib/Rubraca®: A Story of the Synergy Between Science and Serendipity." Cancers 12, no. 3 (2020): 564. http://dx.doi.org/10.3390/cancers12030564.
Full textElen, Elen. "Mombolasuako Perspektif Istihsan Studi di Kecamatan Loea Kabupaten Kolaka Timur." KALOSARA: Family Law Review 4, no. 2 (2024): 101. https://doi.org/10.31332/kalosara.v4i2.5225.
Full textMulesa, Oksana, Yurii Bilak, Yevhenii Kykyna, and Dmytro Ferens. "Development of decision approval rules in multichannel decision-making systems." Technology audit and production reserves 6, no. 2(62) (2021): 6–9. http://dx.doi.org/10.15587/2706-5448.2021.244665.
Full textJung, Sun-Kyu, Won-Chang Kim, Gyu-Yong Kim, and Tae-Gyu Lee. "Improving Building Permit System via Case Analysis of Temporary Buildings in Industrial Facilities." Fire Science and Engineering 38, no. 3 (2024): 18–24. http://dx.doi.org/10.7731/kifse.c0d94c1a.
Full textRaitt, Petrina, and Stacey Fidgeon. "Competency framework: environmental approval specialists." APPEA Journal 59, no. 2 (2019): 698. http://dx.doi.org/10.1071/aj18172.
Full textLamba, Nayan, and Bryan Iorgulescu. "196 Checkpoint blockade therapy for brain-metastatic non-small cell lung cancer: a comparative effectiveness analysis of national data." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (2020): A211. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0196.
Full textGhisa, Claudia, and Kenneth R. Zaslav. "Novel Treatment Options for Knee Cartilage Defects in 2023." Sports Medicine and Arthroscopy Review 32, no. 2 (2024): 113–18. http://dx.doi.org/10.1097/jsa.0000000000000398.
Full textGromova, Mariya, Annegret Vaggelas, Gabriele Dallmann, and Diane Seimetz. "Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape." Biomarker Insights 15 (January 2020): 117727192097465. http://dx.doi.org/10.1177/1177271920974652.
Full textOksana, Mulesa, Bilak Yurii, Kykyna Yevhenii, and Ferens Dmytro. "Development of decision approval rules in multichannel decision-making systems." Technology Audit and Production Reserves 6, no. 2(62) (2021): 6–9. https://doi.org/10.15587/2706-5448.2021.244665.
Full textPowell, Kerrington, and V. Prasad. "Concerning FDA approval of trilaciclib (Cosela) in extensive-stage small-cell lung cancer." Translational Oncology 14, no. 11 (2021): 101206. http://dx.doi.org/10.1016/j.tranon.2021.101206.
Full textDanese, Silvio, Elmer Schabel, Mark Andrew Ainsworth, and Laurent Peyrin-Biroulet. "Challenges and opportunities for IBD drug development: from early stage to regulatory approval." Gut 69, no. 7 (2020): 1157–61. http://dx.doi.org/10.1136/gutjnl-2019-320542.
Full textOliveira, Ana Paula Cavalcante de, Ana Beatriz Zanardo Mion, Helen Fernanda Barbosa Batista, et al. "Prioritization criteria in policies and management of human resources for health: a proposal for a validated methodology." Revista Panamericana de Salud Pública 48 (May 2, 2024): 1. http://dx.doi.org/10.26633/rpsp.2024.39.
Full textSofia, Natalia, Stefan Mühlebach, Umberto M. Musazzi, et al. "How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries." Pharmaceutics 13, no. 7 (2021): 1010. http://dx.doi.org/10.3390/pharmaceutics13071010.
Full textMurphy, David S., and Scott Yetmar. "Petty Corruption in a Multi-Person, Multi-Stage Bureaucratic Process: Formal Models and an Experimental Assessment." Research in Economics and Management 4, no. 1 (2019): 69. http://dx.doi.org/10.22158/rem.v4n1p69.
Full textVOLKOV, ARTEM. "WAYS OF PROTECTING THE RIGHTS OF PERSONS INVOLVED IN CRIMINAL PROCEEDINGS AT THE STAGE OF APPROVAL BY THE PROSECUTOR OF THE ACT ENDING THE PRELIMINARY INVESTIGATION WITH SENDING THE CASE TO COURT." LEGAL BULLETIN 4, no. 8 (2023): 114–22. https://doi.org/10.5281/zenodo.11190399.
Full textSantini, Ario, and Kenneth A. Eaton. "An Introduction to Research for Primary Dental Care Clinicians." Primary Dental Care os18, no. 3 (2011): 127–32. http://dx.doi.org/10.1177/2050168411os1800312.
Full textSantini, Ario, and Kenneth A. Eaton. "An Introduction to Research for Primary Dental Care Clinicians." Primary Dental Care os18, no. 3 (2011): 133–35. http://dx.doi.org/10.1177/2050168411os1800315.
Full textVolkmer, Anna, David A. Copland, Maya L. Henry, et al. "COS-PPA: protocol to develop a core outcome set for primary progressive aphasia." BMJ Open 14, no. 5 (2024): e078714. http://dx.doi.org/10.1136/bmjopen-2023-078714.
Full textHladkykh, Dmytro M., Victoria Oleshko, and Nataliya Berladir. "Role of pembrolizumab in relapsed Hodgkin lymphoma patients." American Journal of BioMedicine 11, no. 4 (2023): 172–85. http://dx.doi.org/10.18081/2333-5106/2023.11/172.
Full textStoen, Ericson, Jodi Kagihara, Elena Shagisultanova, et al. "Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval." Breast Cancer Research and Treatment 187, no. 3 (2021): 883–91. http://dx.doi.org/10.1007/s10549-021-06132-8.
Full textZhao, Jingxuan, Ilana Graetz, David Howard, Robin Yabroff, and Joseph Lipscomb. "Association of immune checkpoint inhibitor introduction and changes in survival disparities by health insurance coverage among individuals newly diagnosed with advanced cancers in the US." Journal of Clinical Oncology 42, no. 16_suppl (2024): 1580. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.1580.
Full textAlmusalami, Eman M., Mohammed I. Al-Bazroun, Amal I. Alhasawi, et al. "Acceptance, Advocacy, and Perception of Health Care Providers on COVID-19 Vaccine: Comparing Early Stage of COVID-19 Vaccination with Latter Stage in the Eastern Region of Saudi Arabia." Vaccines 11, no. 2 (2023): 488. http://dx.doi.org/10.3390/vaccines11020488.
Full textLee, Kyungsik, Hana Yoo, Sumin Shin, et al. "A Submodular Optimization Approach to Accountable Loan Approval." Proceedings of the AAAI Conference on Artificial Intelligence 38, no. 21 (2024): 22761–69. http://dx.doi.org/10.1609/aaai.v38i21.30310.
Full text